Your browser doesn't support javascript.
loading
Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey.
Musengimana, Gentille; Tuyishime, Elysee; Kiromera, Athanase; Malamba, Samuel S; Mulindabigwi, Augustin; Habimana, Madjid R; Baribwira, Cyprien; Ribakare, Muhayimpundu; Habimana, Savio D; DeVos, Josh; Mwesigwa, Richard C N; Kayirangwa, Eugenie; Semuhore, Jules M; Rwibasira, Gallican N; Suthar, Amitabh B; Remera, Eric.
Afiliación
  • Musengimana G; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • Tuyishime E; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Rwanda.
  • Kiromera A; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Rwanda.
  • Malamba SS; 3489University of Maryland, Center for International Health, Education and Biosecurity, (CIHEB), Baltimore, MD USA.
  • Mulindabigwi A; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Rwanda.
  • Habimana MR; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • Baribwira C; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • Ribakare M; 3489University of Maryland, Center for International Health, Education and Biosecurity, (CIHEB), Baltimore, MD USA.
  • Habimana SD; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • DeVos J; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • Mwesigwa RCN; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Atlanta, GA USA.
  • Kayirangwa E; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Rwanda.
  • Semuhore JM; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Rwanda.
  • Rwibasira GN; World Health Organization, Rwanda Office.
  • Suthar AB; Ministry of Health, 1242Rwanda Biomedical Center, HIV/AIDs, STIs and OBBI Division, Kigali City, Rwanda.
  • Remera E; U.S. Centers for Disease Control and Prevention, Center for Global Health, Division of Global HIV & TB, Atlanta, GA USA.
Antivir Ther ; 27(3): 13596535221102690, 2022 06.
Article en En | MEDLINE | ID: mdl-35593031
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: Antivir Ther Asunto de la revista: TERAPIA POR MEDICAMENTOS / VIROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Ruanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: Antivir Ther Asunto de la revista: TERAPIA POR MEDICAMENTOS / VIROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Ruanda